Nice review by superstar IM resident and a future hem/onc fellow @LopedotePaolo on #Mosunetuzumab for #FL Can't wait to see which lucky program will have him! https://t.co/E576IgH2kE
RT @Lymphoma_Papers: Targeted Treatment of Relapsed or Refractory Follicular Lymphoma: Focus on the Therapeutic Potential of Mosunetuzumab…
Targeted Treatment of Relapsed or Refractory Follicular Lymphoma: Focus on the Therapeutic Potential of Mosunetuzumab #lymphoma #lymsm https://t.co/4V5ZugBIsA
Targeted Treatment of Relapsed or Refractory Follicular Lymphoma: Focus on the Therapeutic Potential of Mosunetuzumab #lymphoma #lymsm https://t.co/1HUlVxs1Op
Recently published in Cancer Management and Research: Targeted Treatment of Relapsed or Refractory Follicular Lymphoma: Focus on the Therapeutic Potential of Mosunetuzumab 🔗https://t.co/xO5zvYAW4l #Research #FollicularLymphoma #CancerManagement #Mosunetu